new
   Indications for Deflazacort (Calcort)
506
Sep 25, 2025

Deflazacort (Calcort) is a glucocorticoid drug mainly used for the treatment of various inflammatory and autoimmune diseases.

Indications for Deflazacort (Calcort)

Duchenne Muscular Dystrophy (DMD)

Deflazacort has been approved by the FDA for the treatment of Duchenne Muscular Dystrophy (DMD) in patients aged 5 years and above, which is the primary indication of this drug.

Clinical studies have shown that deflazacort can delay the degeneration of muscle function in DMD patients, improve motor function, and prolong the duration of maintaining walking ability.

Inflammatory and Autoimmune Diseases

Deflazacort can also be used to treat a variety of inflammatory and autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, severe asthma, allergic diseases, etc.

Its anti-inflammatory effect is approximately 70% that of prednisone, but it has relatively fewer side effects.

Specifications and Properties of Deflazacort (Calcort)

Oral Suspension

The specification of the newly approved deflazacort oral suspension is 22.75 mg/mL.

This suspension is a combination product, consisting of the drug and device components.

Tablets

Common specifications of deflazacort tablets include 6 mg, 18 mg, and 30 mg. The tablets are generally white or off-white, and their specific properties may vary slightly among different manufacturers.

The tablets should be swallowed whole and should not be split or crushed.

Storage and Usage of Deflazacort (Calcort)

Storage Conditions

Both deflazacort oral suspension and tablets should be stored at room temperature (20-25°C), and short-term storage in an environment of 15-30°C is allowed.

It is important to keep the drug out of the reach of children, and avoid direct sunlight and humid environments.

The suspension should be kept in intact packaging before opening; after opening, it should be stored in accordance with the requirements in the instruction manual.

Oral Suspension

Shake well thoroughly before use.

Use a dedicated administration device to accurately measure the dosage.

It can be mixed with a small amount of water or fruit juice for administration to improve the taste.

After opening, it must be used up within the specified time.

Tablets

It is recommended to take it after breakfast in the morning to conform to the body's cortisol secretion rhythm.

Swallow the tablets whole; do not chew or crush them.

Patients taking the drug for a long time should not stop taking it suddenly and need to gradually reduce the dosage.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
How to relieve the side effects of Gilteritinib (Xospata)?

Side effect management of Lazertinib requires targeted measures based on specific reaction types, with key focus on...

Friday, February 13th, 2026, 11:29
What are the side effects of Gilteritinib (Xospata)?

Gilteritinib (Xospata) is a FLT3 inhibitor. Its adverse reactions mainly involve the hematological system,...

Friday, February 13th, 2026, 11:01
Where to Buy Venetoclax Tablets

Venetoclax is a targeted medication used for the treatment of chronic lymphocytic leukemia/small lymphocytic...

Thursday, February 12th, 2026, 13:49
Indications of Venetoclax Tablets

Venetoclax is an innovative BCL‑2 inhibitor that plays an important role in the treatment of hematologic...

Thursday, February 12th, 2026, 13:46
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved